Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Katrin Mestermann, Theodoros Giavridis, Justus Weber, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 499
Open Access | Times Cited: 412

Showing 1-25 of 412 citing articles:

CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner, Rosalie M. Sterner
Blood Cancer Journal (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 1757
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1123
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 634
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Emma Morris, Sattva S. Neelapu, Theodoros Giavridis, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 85-96
Open Access | Times Cited: 616
Treg cell-based therapies: challenges and perspectives
Caroline Raffin, Linda T. Vo, Jeffrey A. Bluestone
Nature reviews. Immunology (2019) Vol. 20, Iss. 3, pp. 158-172
Open Access | Times Cited: 538
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 497
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 484
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
Evan W. Weber, Kevin R. Parker, Elena Sotillo, et al.
Science (2021) Vol. 372, Iss. 6537
Open Access | Times Cited: 450
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu, Zeno Riester, Adrian Baldrich, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 405
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 370
The Emerging Landscape of Immune Cell Therapies
Evan W. Weber, Marcela V. Maus, Crystal L. Mackall
Cell (2020) Vol. 181, Iss. 1, pp. 46-62
Open Access | Times Cited: 362
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 294
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
Christian Flugel, Robbie G. Majzner, Giedre Krenciute, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 49-62
Open Access | Times Cited: 243
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
Elizabeth L. Siegler, Saad S. Kenderian
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 214
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
Leila Amini, Sara Silbert, Shannon L. Maude, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 342-355
Closed Access | Times Cited: 208
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Max Jan, Irene Scarfò, Rebecca C. Larson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 575
Open Access | Times Cited: 197
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
Olli Dufva, Jan Koski, Pilvi Maliniemi, et al.
Blood (2019) Vol. 135, Iss. 9, pp. 597-609
Open Access | Times Cited: 184
From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 181
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Axel Hyrenius‐Wittsten, Su Yang, Minhee Park, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 591
Open Access | Times Cited: 168
Cytokines in CAR T Cell–Associated Neurotoxicity
Juliane Gust, Rafael Ponce, W. Conrad Liles, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 160
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 157
<p>Cytokine Release Syndrome: Current Perspectives</p>
Hemant S. Murthy, Madiha Iqbal, Julio C. Chávez, et al.
ImmunoTargets and Therapy (2019) Vol. Volume 8, pp. 43-52
Open Access | Times Cited: 154
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa Hines, Tristan Knight, Kevin O. McNerney, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 438.e1-438.e16
Open Access | Times Cited: 141
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals
Nora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Blood (2022) Vol. 140, Iss. 10, pp. 1104-1118
Open Access | Times Cited: 136
Impact of Manufacturing Procedures on CAR T Cell Functionality
Norihiro Watanabe, Feiyan Mo, Mary K. McKenna
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 121
Page 1 - Next Page

Scroll to top